The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
PLoS announces open access journal for all clinical trials, positive or negative

San Francisco, USA, October 18, 2005 - The Public Library of Science (PLoS) today announces PLoS Clinical Trials, an innovative new journal devoted to peer-reviewing and publishing reports of randomized clinical trials in all areas of healthcare (http://www.plosclinicaltrials.org).

The journal differs from other medical journals in one crucial respect. It will publish all trials that are ethically and scientifically sound and entered into an internationally accepted registry, regardless of the trial's size or whether the results are positive or negative. PLoS Clinical Trials is now accepting manuscripts in advance of its spring 2006 launch.

Around half of all completed trial reports are thought to go unpublished. These unpublished trial reports differ systematically from those that are published in the direction and strength of the findings, thus distorting the evidence base for decision-making in healthcare.

"Unpublished results undermine the trust between patients and investigators and slow the vast potential of medical progress," says Dr Christian Gluud of Copenhagen University Hospital, a member of the Advisory Board of PLoS Clinical Trials.

Traditional medical journals publish only the highest profile clinical trials (typically positive trials), partly because the journals must attract revenues from subscriptions and selling reprints. PLoS Clinical Trials avoids this problem--it doesn't have to sell subscriptions or reprints to be viable, so it can publish the broadest range of trials.


'"/>

Contact: Paul Ocampo
press@plos.org
415-624-1224
Public Library of Science
17-Oct-2005


Page: 1

Related medicine news :

1. W.M. Keck Foundation announces 2007 class of Distinguished Young Scholars in medical research
2. AstraZeneca announces SYMBICORT is now available in the US
3. Weill Cornell Medical College announces gifts totaling $400M
4. GSK announces launch of largest ever Phase III trial in lung cancer treatment
5. Elsevier announces launch of Brain Stimulation
6. NSW Premier announces $15M for childrens cancer research
7. National Inventors Hall of Fame announces 2007 inductees
8. Emory University announces new Global Health Institute
9. BioMed Central announces Journal of Medical Case Reports
10. Tibotec Therapeutics announces start of largest US study on HIV treatment in women
11. Wiley announces partnership with NASPGHAN and AASLD

Post Your Comments:
(Date:11/24/2009)...PlusofMichiganhaslaunchedfournew HealthPlusSignatu...s18to64andtheirfamilieswhoarelookingtopurchaseaffo...lusSignature plansareavailableonlineat www.HealthP...althPlusservicearea.Moreinformation,includinghelpw...o1-877-562-0907. ,, "Wearepleasedtoofferanarray...
(Date:11/24/2009)...of inflammatory bowel disease is largely unknown, ...9 Advances in Inflammatory Bowel Diseases, the Cro...al & Research Conference, December 3-6 in Holl...tion for Crohn’s disease. , ... The molecular cause of inflammatory bowel disease...
(Date:11/24/2009)...eholidayseasonoftenbringsfamiliesandfriendstogethe...segrievingthedeathofalovedone.Followingadeath,ever...asoncanbringadditionalchallengestothosewhoaregriev...ngChildren,AdolescentsandTheirFamilies,isavailable...fprintandonlineresourcesavailabletohelpchildrengri...
(Date:11/24/2009)...tCall/--HealthSouthCorporation(NYSE: HLS )todayann...nch2009CreditConferenceinNewYorkonDec.2-3,2009. ,...ywillbespeakingonThursday,Dec.3,2009,at3:40p.m.ET....at http://investor.healthsouth.com byclickingonana...hSouthisthenation,slargestproviderofinpatientrehab...
(Date:11/24/2009)...between high- and low-volume centers, study found ... Do hospitals that conduct the most angioplasties ... Maybe not. , Prior research had suggested that...opening procedures, but a new study involving over...als performing more or less equally. , The stud...
Breaking Medicine News(10 mins):Health News:HealthPlus Offers New Insurance Plans for Consumers Seeking Health Coverage on Their Own 2Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 2Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 3Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 4Health News:Highmark Caring Place Resources Help Children and Families Who Are Grieving During the Holidays 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 3
(Date:11/24/2009)...KE,N.J.andNEWYORK,Nov.24/PRNewswire/-- EisaiInc.a...inistration(FDA)hasacceptedforreviewEisai,sNewDrug...pezilHClextendedrelease)tabletsforthetreatmentofmo...doseformulationcontains23mgofdonepezilHClinanexten...tallowsforgradualreleaseofthedrug.TheNDAisbasedona...
(Date:11/24/2009)....,Nov.24/PRNewswire/--PharmaceuticalInstitute,alea...armaceuticalandbiotechindustry,todayannouncedthela...new HospitalMarketplace e-courseisthenewestadditio...s,acomprehensiveseriesofe-coursesdesignedtofillthe...edgeforcommercialprofessionals. ,, Thenewthreem...
(Date:11/24/2009)...,Ontario,Nov.24/PRNewswire-FirstCall/--CardioGenic...echnologyandproductstargetingtheimmunoassaysegment...("MerckChimie")isprogressingtothenextphaseofthecom...edparamagneticBeads("Beads"). ,, Pertheagreemen...dioGenicssuppliedMerckChimiewithitsproprietarysilv...
Breaking Medicine Technology:FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Pharmaceutical Institute Launches New Training Resource Focused on the Hospital Marketplace 2CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 2CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 3Sigma Aldrich 28Nasdaq 3A SIAL 29 Declares Quarterly Dividend 13508 1Really Think Different 54252 1Really Think Different 54252 2Introducing All New IEHP Superhero to Battle Childhood Obesity 54248 1Introducing All New IEHP Superhero to Battle Childhood Obesity 54248 2Introducing All New IEHP Superhero to Battle Childhood Obesity 54248 3
Other News:
CHICAGO, June 2 Higher levels of a protein called S-100 in patients with melanoma may correlate with a higher risk of having the disease return, say researchers at the University of Pittsburgh Cancer
...line (GSK) today announced results from ongoing Ph...tic renal cell carcinoma (RCC) and ovarian cancer....eting of the American Society of Clinical Oncology... trials with pazopanib support further investigati...
...oard and pen that patients typically encounter whe...oon be replaced by wireless, handheld notebook-and... in some community cancer clinics have been using ...ke University Comprehensive Cancer Center research...
...t temper or mean disposition also tend to have com...hed in the journal Health Psychology, by the Ameri... even when asthma and smoking were ruled out as po...f 4,629 Black and White 18-30 year olds from four ...
health news:Protein may be linked to melanoma recurrence 2health news:GSK's Pazopanib shows positive results in patients with advanced RCC and ovarian cancer 2health news:GSK's Pazopanib shows positive results in patients with advanced RCC and ovarian cancer 3health news:E/Tablet technology may provide benefits to patients, researchers 2health news:Harboring hostility may be linked to unhealthy lungs 2
... 6, 2004) -- Scientists at The Hospital for Sick C...he first time a region of the brain responsible fo...search is reported in the May 7, 2004 issue of the...at the hippocampus processes recent memory, but th...
..., May 6, 2004 Shire Pharmaceuticals Group plc (NA...at adults with attention-deficit/hyperactivity dis...control when treated with once-daily ADDERALL XR (...interim analysis of a two-year Phase III trial led...
...y 6 -- Adults with attention-deficit/hyperactivity...ion, but have they outgrown its effects? Findings...Attention," indicate that adults with ADHD experie...ir lives, including educational and professional a...
...f drugs available to treat epilepsy have more than...ademy of Neurology and the American Epilepsy Socie...evaluate the available data of 1,462 research arti...ent of epilepsy with the new antiepileptic drugs (...
health news:Scientists uncover how brain retrieves and stores older memories 2health news:Long-term study proves ADDERALL XR is a safe and effective option to treat adults with ADHD 2health news:Long-term study proves ADDERALL XR is a safe and effective option to treat adults with ADHD 3health news:Long-term study proves ADDERALL XR is a safe and effective option to treat adults with ADHD 4health news:Long-term study proves ADDERALL XR is a safe and effective option to treat adults with ADHD 5health news:Survey of adults reveals life-long consequences of ADHD 2health news:Survey of adults reveals life-long consequences of ADHD 3health news:Survey of adults reveals life-long consequences of ADHD 4health news:American Academy of Neurology guidelines for treating of epilepsy 2health news:American Academy of Neurology guidelines for treating of epilepsy 3